Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland

United Kingdom of Great Britain and Northern Ireland: Proportion of isolates with decreased susceptibility or resistance was 1.2 in 2018. ◆ Volatile

Latest (2018)
1.2
Change on year
down 7.7%
World rank
11th
of 27 countries
All-time high
3.15
in 2010
All-time low
0
in 2009
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland, 2009–2018

01232009201320182009: 02010: 3.22011: 2.82012: 02013: 0.8332014: 02015: 0.4182016: 0.8582017: 1.32018: 1.2

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland is 1.2, measured in 2018.

Compared with earlier readings it is down 7.7% on the previous year and up 44.0% over five years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland peaked at 3.15 in 2010 and was at its lowest, 0, in 2009.

That places United Kingdom of Great Britain and Northern Ireland 11th out of 27 countries with data for 2018, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP in United Kingdom of Great Britain and Northern Ireland, 2009 to 2018.
Year Value Change
2009 0
2010 3.15
2011 2.79 -11.6%
2012 0 -100.0%
2013 0.8333
2014 0 -100.0%
2015 0.4184
2016 0.8584 +105.2%
2017 1.3 +51.4%
2018 1.2 -7.7%

United Kingdom of Great Britain and Northern Ireland compared with similar countries

  • United Kingdom of Great Britain and Northern Ireland's 1.2 is above the median for Europe & Central Asia, which is 1, 1.2× the median. (23 countries reporting)
  • United Kingdom of Great Britain and Northern Ireland's 1.2 is above the median for high income countries, which is 0.2907, 4.1× the median. (25 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 0 0 0 1
2010s 1.17 0 3.15 9

Countries ranked near United Kingdom of Great Britain and Northern Ireland

  1. 8 Hungary 2.2 compare
  2. 9 Sweden 1.5 compare
  3. 10 Poland 1.4 compare
  4. 12 Germany 1 compare
  5. 13 Canada 0.5445 compare
  6. 14 United States of America 0.2907 compare

See the full ranking of 27 places →

More health data for United Kingdom of Great Britain and Northern Ireland

All data for United Kingdom of Great Britain and Northern Ireland →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland?
Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland was 1.2 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in United Kingdom of Great Britain and Northern Ireland?
The highest recorded value was 3.15 in 2010.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in United Kingdom of Great Britain and Northern Ireland?
The lowest recorded value was 0 in 2009.
How does United Kingdom of Great Britain and Northern Ireland rank for proportion of isolates with decreased susceptibility or resistance?
United Kingdom of Great Britain and Northern Ireland ranks 11th out of 27 countries with data for 2018.
Where does this United Kingdom of Great Britain and Northern Ireland data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 13 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/united-kingdom/">Proportion of isolates with decreased susceptibility or resistance in United Kingdom of Great Britain and Northern Ireland</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
27 places, 246 data points, 2009–2018
Last refreshed